The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by an incompletely reversible limitation in airflow. A physiological variable--the forced expiratory volume in one second (FEV1)--is often used to grade the severity of COPD. However, patients with COPD have systemic manifestations that are not reflected by the FEV1. We hypothesized that a multidimensional grading system that assessed the respiratory and systemic expressions of COPD would better categorize and predict outcome in these patients. METHODS: We first evaluated 207 patients and found that four factors predicted the risk of death in this cohort: the body-mass index (B), the degree of airflow obstruction (O) and dyspnea (D), and exercise capacity (E), measured by the six-minute-walk test. We used these variables to construct the BODE index, a multidimensional 10-point scale in which higher scores indicate a higher risk of death. We then prospectively validated the index in a cohort of 625 patients, with death from any cause and from respiratory causes as the outcome variables. RESULTS: There were 25 deaths among the first 207 patients and 162 deaths (26 percent) in the validation cohort. Sixty-one percent of the deaths in the validation cohort were due to respiratory insufficiency, 14 percent to myocardial infarction, 12 percent to lung cancer, and 13 percent to other causes. Patients with higher BODE scores were at higher risk for death; the hazard ratio for death from any cause per one-point increase in the BODE score was 1.34 (95 percent confidence interval, 1.26 to 1.42; P<0.001), and the hazard ratio for death from respiratory causes was 1.62 (95 percent confidence interval, 1.48 to 1.77; P<0.001). The C statistic for the ability of the BODE index to predict the risk of death was larger than that for the FEV1 (0.74 vs. 0.65). CONCLUSIONS: The BODE index, a simple multidimensional grading system, is better than the FEV1 at predicting the risk of death from any cause and from respiratory causes among patients with COPD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The BODE index [BMI, airflow limitation (forced expiratory volume in one second), dyspnea and 6-min walk distance], which has been externally validated in at least 13 additional cohorts following the original derivation. The BODE index has been cited as the prognostic model of choice by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), and it formed the basis for listing recommendations in the 2014 ISHLT candidate selection guidelines. (4, 166–168)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [166]
In the citing paper
“Although COPD remains the most common indication for lung transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
In the citing paper
“the BODE score (body mass index, degree of airway obstruction, dyspnea, and exercise capacity score) is still the most important indicator, and along with it, FEV1 and the presence or absence of acute exacerbation determine whether transplantation is possible based on the presence or absence of evidence for pulmonary arterial hypertension (PAH), as summarized in Table 2 [3,42].”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Lung Function Testing: Selection of Reference Values and Interpretative Strategies
(1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1202 · Cited by 2,510
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Evaluation of Clinical Methods for Rating Dyspnea
Mahler, D. A., & Wells, C. K. (1988) · Chest · doi:10.1378/chest.93.3.580 · Cited by 1,822
Research works printed but not linked: 1
- Burrows B, 1991, Eur Respir Rev, 1, 340
Cited by
Items 501–600 of 1,007
Mannino, D. M., & Diaz‐Guzman, E. (2011) · CHEST Journal · doi:10.1378/chest.11-0797 · Cited by 86
Chronic obstructive pulmonary disease prevalence in Lebanon: a cross-sectional descriptive study
Waked, M., Khayat, G., & Salameh, P. (2011) · Clinical Epidemiology · doi:10.2147/clep.s26350 · Cited by 85
“Abbreviations: COPD, chronic obstructive pulmonary disease; GOLD, Global initiative for Chronic Obstructive Lung Disease.”
InfluentialThe clinical management in extremely severe COPD.
Ambrosino, N., & Simonds, A. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.02.011 · Cited by 87
“Several studies provide scientific evidence that rehabilitation improves several of the variables associated with poor outcomes, such as exercise capacity and dyspnoea,(49) as well as the multidimensional BODE index.(50,51) In the study(51) the changes in the BODE index induced by rehabilitation were predictive of fin…”
BackgroundSand, J. M. B., Leeming, D. J., Byrjalsen, I., Bihlet, A. R., Lange, P., Tal‐Singer, R., Miller, B. E., Karsdal, M. A., & Vestbo, J. (2016) · Respiratory Research · doi:10.1186/s12931-016-0440-6 · Cited by 82
“Using multidimensional risk scores [6] or adding markers of systemic inflammation [7] adds to the predictive value, exceeding the prognostic value of lung function alone.”
BackgroundKwan, H. Y., Maddocks, M., Nolan, C. M., Jones, S. E., Patel, S., Barker, R. E., Kon, S. S. C., Polkey, M. I., Cullinan, P., & Man, W. D. ‐. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12463 · Cited by 80
“This large prospective cohort study found a prevalence of 4.6% and 1.6% for cachexia and pre-cachexia in outpatients with stable COPD.”
BackgroundInfluentialChronic Bronchitis and Emphysema
Shapiro, S. D., Reilly, J. J., & Rennard, S. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00039-0 · Cited by 87
Wouters, E. F. �. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16984-5 · Cited by 92
O'Reilly, J. F., Jones, M. M., Parnham, J., Lovibond, K., Rudolf, M., & on behalf of the Guideline Development Group (2010) · BMJ · doi:10.1136/bmj.c3134 · Cited by 79
Comes, A., Wong, A. W., Fisher, J. H., Morisset, J., Johannson, K. A., Farrand, E. D., Fell, C. D., Kolb, M. R. J., Manganas, H., Cox, G., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.11.008 · Cited by 86
Symptom-Based Questionnaire for Differentiating COPD and Asthma
Tinkelman, D. G., Price, D. B., Nordyke, R. J., Halbert, R. J., Isonaka, S., Nonikov, D., Juniper, E. F., Freeman, D., Hausen, T., Levy, M. L., et al. (2005) · Respiration · doi:10.1159/000090141 · Cited by 79
“Since our goal was to facilitate spirometry as the primary diagnostic maneuver, we focused on identifying persons with fixed (postbronchodilator) obstruction. The strongest discriminators for fixed obstruction were increasing age and pack-years of smoking, dyspnea that worsened in recent years, breathing-related hospi…”
BackgroundMechanisms and measurement of dyspnea in chronic obstructive pulmonary disease.
Mahler, D. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200509-103sf · Cited by 90
“In addition, initial scores on the MRC scale have been shown to predict survival in patients with COPD (37, 38 ).”
BackgroundMomen, N. C., Hadfield, P., Kuhn, I. L., Smith, E., & Barclay, S. I. G. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201835 · Cited by 79
“The best current prognostic model is the BODE Index, which is better at predicting death than forced expiratory volume in 1 s (FEV1) alone.(6) As with all such models, this is of some use with groups of patients but of little help with individuals.”
MethodAnemia is a Mortality Predictor in Hospitalized Patients for COPD Exacerbation
Martínez‐Rivera, C., Portillo, K., Muñoz-Ferrer, A., Martínez-Ortiz, M. L., Molins, E., Serra, P., Ruíz, J., & Morera, J. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.647131 · Cited by 79
Multidimensional prognostic indices for use in COPD patient care. A systematic review
van Dijk, W. D., van den Bemt, L., van den Haak-Rongen, S., Bischoff, E., van Weel, C., in 't Veen, J. C., & Schermer, T. R. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-151 · Cited by 79
“Correlation with another index [43] was the only”
BackgroundResultInfluentialCrimi, C., Heffler, E. M., Augelletti, T., Campisi, R., Noto, A., Vancheri, C., & Crimi, N. (2018) · International Journal of COPD · doi:10.2147/copd.s171134 · Cited by 78
Impact of self-reported Gastroesophageal reflux disease in subjects from COPDGene cohort
Martinez, C. H., Okajima, Y., Murray, S., Washko, G. R., Martínez, F. J., Silverman, E. K., Lee, J., Regan, E. A., Crapo, J. D., Curtis, J. L., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-62 · Cited by 84
“George’s Respiratory Questionnaire (SGRQ) [11], Medical Outcomes Study Short Form (SF) 36 version 2, and the BODE index score was calculated for all patients [12].”
MethodZapatero, A., Barba, R., Ruiz, J. R., Losa, J. E., Plaza, S., Canora, J., & Marco, J. (2013) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12088 · Cited by 92
Domínguez, J., Lacoma, A., Prat, C., Andreo, F., Lores, L., Manzano, J. R., & Ausina, V. (2011) · International Journal of COPD · doi:10.2147/copd.s16070 · Cited by 78
Biomarkers in chronic obstructive pulmonary disease
Rosenberg, S. R., & Kalhan, R. (2012) · Translational research · doi:10.1016/j.trsl.2012.01.019 · Cited by 90
Lee, S. J., Lee, H. R., Lee, T. W., Ju, S., Lim, S., Go, S., You, J.-W., Cho, Y. J., Lee, G., Jeong, Y. Y., et al. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.084 · Cited by 79
Factors Limiting Exercise Tolerance in Chronic Lung Diseases
Vogiatzis, I., & Zakynthinos, S. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110015 · Cited by 77
“In Chronic Obstructive Pulmonary Disease (COPD), besides lung dysfunction, exercise intolerance and breathlessness, as well as peripheral muscle wasting, have been identified as factors related to adverse prognosis (48,208,281).”
Lung Function Abnormalities in Smokers with Ischemic Heart Disease
Franssen, F. M. E., Soriano, J. B., Roche, N., Bloomfield, P. H., Brusselle, G., Fabbri, L. M., Rio, F. G., Kearney, M. T., Kwon, N., Lundbäck, B., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2480oc · Cited by 80
Burgel, P., Paillasseur, J.-L., & Roche, N. (2014) · BioMed Research International · doi:10.1155/2014/420134 · Cited by 87
“Several multidimensional prognostic indices have been developed in COPD [19], the BODE index being one of the most widely quoted [20].”
Background6-Minute walk test in patients with COPD: clinical applications in pulmonary rehabilitation
JENKINS, S. C. (2007) · Physiotherapy · doi:10.1016/j.physio.2007.02.001 · Cited by 93
Survival impact of lung transplantation for COPD
Lahzami, S., Bridevaux, P., Soccal, P. M., Wellinger, J., Róbert, J., Ris, H.-B., & Aubert, J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00087809 · Cited by 84
“In 2004, Celli and co-workers identified from a large multicenter cohort of COPD patients, a combination of four variables which showed a strong association with survival in COPD: body-mass index (B), airflow obstruction (O), dyspnea (D) and exercise capacity (E) [13].”
BackgroundMethodResultInfluentialNyberg, A., Saey, D., & Maltais, F. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201505-278ps · Cited by 88
Nizet, T. A. C., van den Elshout, F. J. J., Heijdra, Y. F., van de Ven, M. J. T., Mulder, P. G. H., & Folgering, H. T. M. (2005) · CHEST Journal · doi:10.1378/chest.127.6.1904 · Cited by 76
Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?
Stone, I. S., Barnes, N. C., & Petersen, S. E. (2012) · Heart · doi:10.1136/heartjnl-2012-301759 · Cited by 89
Chronic obstructive pulmonary disease: an overview.
Devine, J. F. (2008) · Europe PMC (PubMed Central) · Cited by 132
Comorbidities and COPD severity in a clinic-based cohort
Rahérison, C., Ouaalaya, E. H., Bernady, A., Casteigt, J., Nocent-Eijnani, C., Falque, L., Guillou, F. L., Nguyen, L., Ozier, A., & Molimard, M. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0684-7 · Cited by 80
Treatable traits in acute exacerbations of chronic airway diseases
McDonald, V. M., Osadnik, C. R., & Gibson, P. G. (2019) · Chronic Respiratory Disease · doi:10.1177/1479973119867954 · Cited by 83
“6-minute walk distance <350 m or <80% of predicted value using appropriate reference equations for specific population.(92) <7000 steps/day via objective monitor(93,94); ‘Low’ score on International Physical Activity Questionnaire; Failure to Quadriceps weakness during AECOPD only partially recovers 3 months after dis…”
MethodGender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease
de-Torres, J. P., Casanova, C., de Garcini, A. M., Aguirre‐Jaime, A., & Celli, B. R. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-18 · Cited by 77
“Functional dyspnea has been shown to be a strong predictor of survival [8,19], and an important treatable symptom of the disease [20].”
BackgroundSelf-citationControversies in treatment of chronic obstructive pulmonary disease
Rabe, K. F., & Wedzicha, J. A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61295-6 · Cited by 81
Dieplinger, B., Gegenhuber, A., Kaar, G., Poelz, W., Haltmayer, M., & Mueller, T. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.02.002 · Cited by 75
Miravitlles, M., Naberán, K., Cantoni, J., & Azpeitia, Á. (2011) · Respiration · doi:10.1159/000328766 · Cited by 82
“which also limits the possible application of other severity scales such as the BODE index [”
Chronic obstructive pulmonary disease as a risk factor for lung cancer
Takiguchi, Y., Sekine, I., Iwasawa, S., Kurimoto, R., & Tatsumi, K. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i4.660 · Cited by 82
The International Primary Care Respiratory Group (IPCRG) Research Needs Statement 2010
Pinnock, H., Thomas, M. D., Tsiligianni, I., Lisspers, K., Østrem, A., Ställberg, B., Yusuf, O. M., Ryan, D. P., Buffels, J., Cals, J., et al. (2010) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2010.00021 · Cited by 80
Zambom-Ferraresi, F., Cebollero, P., Gorostiaga, E. M., Hernández, M., Hueto, J., Rodrigo, J. A. C., Sagasti, L. R., Val, L., & Antón, M. M. (2015) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000132 · Cited by 83
A qualitative study of patients' goals and expectations for self-management of COPD
Wortz, K., Cade, A., Menard, J. R., Lurie, S. G., Lykens, K., Bae, S., Jackson, B. E., Su, F.-H., Singh, K. P., & Coultas, D. (2012) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2012.00070 · Cited by 87
Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model
Lüthje, L., Raupach, T., Michels, H., Unsöld, B. W., Hasenfuss, G. P., Kögler, H., & Andreas, S. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-7 · Cited by 78
“Recently the BODE index, which includes body mass index, airflow obstruction, dyspnoea and exercise capacity, has been shown to be a stronger predictor of COPD prognosis than FEV1 [3].”
BackgroundInfluentialIntegrating Palliative Care in Severe Chronic Obstructive Lung Disease
Hardin, K. A., Meyers, F. J., & Louie, S. (2008) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550802237366 · Cited by 74
Selecting lung transplant candidates: where do current guidelines fall short?
Hook, J. L., & Lederer, D. J. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.83 · Cited by 73
López‐Sánchez, M., Muñoz‐Esquerre, M., Huertas, D., González‐Costello, J., Ribas, J., Manresa, F., Dorca, J., & Santos, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068034 · Cited by 86
“For patients with severe disease, the 6MWT shows marked differences between individuals, so that the current multi-dimension indexes that include this parameter, such as BODE, are better predictors than the FEV1 which are used individually [25].”
BackgroundThe cardiopulmonary continuum systemic inflammation as ‘common soil’ of heart and lung disease
Ukena, C., Mahfoud, F., Kindermann, M., Kindermann, I., Bals, R., Voors, A. A., van Veldhuisen, D. J., & Böhm, M. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.04.082 · Cited by 85
Hyperinflation and its management in COPD
Puente-Maestu, L., & Stringer, W. (2006) · International Journal of COPD · doi:10.2147/copd.2006.1.4.381 · Cited by 81
“…et al 1996; Bowen et al 2000; Myers et al 2002; Hiraga et al 2003; Oga et al 2003) or 6 minute walking distance (Pinto-Plata et al 2004), dyspnea (Celli et al 2004), and oxygen desaturation (Nishimura et al 2002; Hiraga et al 2003; Tojo et al 2005) during exercise have been show to be powerful…”
BackgroundSeverity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice
Hoogendoorn, M., Feenstra, T., Schermer, T. R., Hesselink, A. E., & Mölken, M. R. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.04.004 · Cited by 75
“walk distance and body mass index.(12) However, as this is only a recent development, no routine registrations exist that generate these data for epidemiological use yet.”
BackgroundFamily History Is a Risk Factor for COPD
Hersh, C. P., Hokanson, J. E., Lynch, D. A., Washko, G. R., Make, B. J., Crapo, J. D., & Silverman, E. K. (2011) · CHEST Journal · doi:10.1378/chest.10-2761 · Cited by 82
Agustí, A. G. N., Antó, J. M., Auffray, C., Barbé, F., Barreiro, E., Dorca, J., Escarrabill, J., Faner, R., Furlong, L. I., García‐Aymerich, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1935pp · Cited by 78
López, C. C., Macario, C. C., Marín, J. M., de-Torres, J. P., Torres, R. S., González-Martín, J. M., Polverino, F., Divo, M. J., Pinto-Plata, V., Zulueta, J. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1363oc · Cited by 73
Self-citationSurvival in COPD patients treated with bronchoscopic lung volume reduction
Hartman, J. E., Welling, J. B. A., Klooster, K., Carpaij, O. A., Augustijn, S. W. S., & Slebos, D. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.106825 · Cited by 74
Chung, L. P., Winship, P., Phung, S., Lake, F., & WATERER, G. W. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01795.x · Cited by 73
Leptin as regulator of pulmonary immune responses: Involvement in respiratory diseases
Vernooy, J. H. J., Ubags, N. D. J., Brusselle, G., Tavernier, J. H., Suratt, B. T., Joos, G., Wouters, E. F. �., & Bracke, K. R. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.03.016 · Cited by 81
Prognostic assessment in COPD: Health related quality of life and the BODE index
Marín, J. M., Côté, C., Orlando Díaz, P., Lisboa, C., Casanova, C., López, M. V., Carrizo, S. J., Pinto-Plata, V., Dordelly, L. J., Nekach, H., et al. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.01.007 · Cited by 87
Self-citationGao, P., Zhang, J., He, X.-Y., Hao, Y., Wang, K., & Gibson, P. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057678 · Cited by 74
“All of the patients were subjected to BODE evaluation [15], chest CT, and clinical assessments.”
MethodIncreased Expression of Beta-Defensin 1 (DEFB1) in Chronic Obstructive Pulmonary Disease
Andresen, E., Günther, G., Bullwinkel, J., Lange, C. G., & Heine, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021898 · Cited by 73
“The 6-min walking test (6MWD), arterial blood gas analysis, assessment of the MRC dypnoea scale and calculation of probability of survival based on BODE score [18] completed the clinical investigations.”
MethodAnemia, costs and mortality in Chronic Obstructive Pulmonary Disease
Halpern, M. T., Zilberberg, M. D., Schmier, J. K., Lau, E., & Shorr, A. F. (2006) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-4-17 · Cited by 73
“Moreover, other than the recently proposed BODE index, no global, validated severity score in COPD exists [22].”
Factors associated with change in exacerbation frequency in COPD
Donaldson, G. C., Müllerová, H., Locantore, N., Hurst, J. R., CALVERLEY, P. M. A., Vestbo, J., Anzueto, A., & Wedzicha, J. A. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-79 · Cited by 73
“The patients underwent a six minute walking test (6MWD) according to ATS guidelines [15], with distance expressed as a percentage of predicted [16] which was used in calculating the patient’s BODE index [17].”
MethodFerrari, M., Manea, L., Anton, K., Bruzzone, P., Meneghello, M., Zamboni, F., Purgato, L., Cazzoletti, L., Ferrari, P., & Testi, R. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0050-y · Cited by 86
“BODE index, a composite index of COPD severity, was also calculated [23].”
BackgroundNathan, S. D. (2005) · CHEST Journal · doi:10.1378/chest.127.3.1006 · Cited by 94
The Utility of Preoperative Six-Minute-Walk Distance in Lung Transplantation
Castleberry, A. W., Englum, B. R., Snyder, L. D., Worni, M., Osho, A. A., Gulack, B. C., Palmer, S. M., Davis, R. D., & Hartwig, M. G. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201409-1698oc · Cited by 72
“This metric has been shown to accurately predict survival in several pulmonary diseases including chronic obstructive pulmonary disease (5, 6), idiopathic pulmonary fibrosis (7), and primary”
BackgroundRio, F. G., Soriano, J. B., Miravitlles, M., Muñoz, L., Duran‐Tauleria, E., Sánchez, G., Sobradillo, V., & Ancochea, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105220 · Cited by 77
Dyspnea Review for the Palliative Care Professional: Assessment, Burdens, and Etiologies
Kamal, A. H., Maguire, J. M., Wheeler, J. L., Currow, D. C., & Abernethy, A. P. (2011) · Journal of Palliative Medicine · doi:10.1089/jpm.2011.0109 · Cited by 83
The COPD Biomarker Qualification Consortium (CBQC)
Casaburi, R. H., Celli, B. R., Crapo, J. D., Criner, G. J., Croxton, T. L., Gaw, A. J., Jones, P., Kline-Leidy, N., Lomas, D. A., Merrill, D. D., et al. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.752807 · Cited by 72
Self-citationSabino, P. G., Silva, B. M., & Brunetto, A. F. (2010) · Clinics · doi:10.1590/s1807-59322010000600007 · Cited by 80
“Some studies have included overweight or obese patients, but they did not analyze these patients separately.(8,14,18,21) The few previous studies that present data on the influence of being overweight or obese on the exercise capacity of patients with severe COPD report conflicting results.”
BackgroundResultRecent Advances in Computed Tomography Imaging in Chronic Obstructive Pulmonary Disease
Bodduluri, S., Reinhardt, J. M., Hoffman, E. A., Newell, J. D., & Bhatt, S. P. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201705-377fr · Cited by 72
Cosío, B. G., Soriano, J. B., López-Campos, J. L., Rubio, M. C., Soler‐Cataluña, J. J., de-Torres, J. P., Marín, J. M., González, C. M., de Lucas, P., Mir, I., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160770 · Cited by 71
Miravitlles, M., Soler‐Cataluña, J. J., Rubio, M. C., Molina, J., Almagro, P., Quintano, J. A., Trigueros, J. A., Cosío, B. G., Casanova, C., Riesco, J. A., et al. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2017.03.017 · Cited by 151
Self-citationSystemic and airway inflammation and the presence of emphysema in patients with COPD
Papaioannou, A. Ι., Mazioti, A., Kiropoulos, T. S., Tsilioni, I., Koutsokera, A., Tanou, K., Nikoulis, D. J., Georgoulias, P., Zakynthinos, Ε., Gourgoulianis, K. I., et al. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.09.016 · Cited by 77
“Dyspnea was assessed with the modified Medical Research Council (MRC) scale(19) and BODE index was determined.(20) HRQoL was assessed with Saint George’s Respiratory Questionnaire.”
MethodRanucci, M., Ballotta, A., Rovere, M. T. L., & Castelvecchio, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093992 · Cited by 80
“Additionally, underweight is common in patients with chronic obstructive pulmonary disease [25], and is a risk factor for mortality in this group of patients for any degree of severity of the disease [26].”
BackgroundNutritional State during COPD Exacerbation: Clinical and Prognostic Implications
Girón, R. M., Matesanz, C. M., Rio, F. G., Santiago, E., Mancha, A., Salvanés, F. R., & Ancochea, J. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000205960 · Cited by 79
Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study
Jithoo, A., Enright, P., Burney, P., Buist, A. S., Bateman, E. D., Tan, W. C., Studnicka, M., Mejza, F., Gillespie, S., & Vollmer, W. M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00132011 · Cited by 71
Palliative care provision for patients with chronic obstructive pulmonary disease
Yohannes, A. M. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-17 · Cited by 85
The GOLD Classification Has Not Advanced Understanding of COPD
Kerstjens, H. A. M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2405010 · Cited by 72
Pomiès, P., Blaquière, M., Maury, J., Mercier, J., Gouzi, F., & Hayot, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160092 · Cited by 70
“) lower than 50% predicted, moderate exercise limitation and muscle dysfunction as indicated by moderately reduced 6-minute walking distance (6MWD) and quadriceps muscle voluntary contraction (qMVC) values compared with predicted values, and a high BODE index [18].”
BackgroundPolymorphic variation in surfactant protein B is associated with COPD exacerbations
Foreman, M. G., DeMeo, D. L., Hersh, C. P., Carey, V. J., Fan, V. S., Reilly, J. J., Shapiro, S. D., & Silverman, E. K. (2008) · European Respiratory Journal · doi:10.1183/09031936.00040208 · Cited by 71
“The BODE index [18], a composite multidimensional score, was modified to include the post-pulmonary rehabilitation FEV1 values, 6-minute walk test, body mass index (BMI), and the University of California San Diego Pulmonary Rehabilitation Shortness-of-Breath Questionnaire.”
MethodGuler, S. A., Hur, S. A., Lear, S. A., Camp, P. G., & Ryerson, C. J. (2019) · Respiratory Research · doi:10.1186/s12931-019-1019-9 · Cited by 75
“The importance of limb muscle dysfunction on quality of life, adverse health outcomes, and mortality is well recognized in the general aging population [8], and in patients with chronic obstructive pulmonary disease (COPD) [9], but there are limited data from patients with ILD.”
BackgroundInfluentialMultimorbidity in Patients with Chronic Obstructive Pulmonary Disease
Divo, M. J., & Celli, B. R. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.002 · Cited by 81
Self-citationChronic Obstructive Pulmonary Disease: An Update on Diagnosis and Management Issues in Older Adults
Nazir, S. A., & Erbland, M. L. (2009) · Drugs & Aging · doi:10.2165/11316760-000000000-00000 · Cited by 83
Spirometry in primary care case-identification, diagnosis and management of COPD
Price, D. B., Crockett, A. J., Arne, M., Garbe, B., Jones, R. C. M., Kaplan, A. G., Langhammer, A., Williams, S., & Yawn, B. P. (2009) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2009.00055 · Cited by 70
Osteoporosis Prevalence and Associated Factors in Patients With COPD: A Cross-Sectional Study
Silva, D. R., Coelho, A. C., Dumke, A., Valentini, J. D., Nunes, J., Stefani, C. L., Mendes, L. F. D. S., & Knorst, M. M. (2011) · Respiratory Care · doi:10.4187/respcare.01056 · Cited by 81
Disease progression in young patients with COPD: rethinking the Fletcher and Peto model
Sánchez-Salcedo, P., Divo, M. J., Casanova, C., Pinto-Plata, V., de-Torres, J. P., Côté, C., Cabrera, C., Zagaceta, J., Rodriguez‐Roisin, R., Zulueta, J. J., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00208613 · Cited by 75
Self-citationMarco, E., Sánchez‐Rodríguez, D., Dávalos‐Yerovi, V., Durán, X., Pascual, E. M., Muniesa, J. M., Rodriguez, D. A., Aguilera-Zubizarreta, A., Escalada, F., & Duarte, E. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.09.014 · Cited by 75
Daily physical activity and related risk factors in COPD
Albarrati, A., Gale, N., Munnery, M. M., Cockcroft, J., & Shale, D. J. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-1097-y · Cited by 73
Bikov, A., Lange, P., Anderson, J. A., Brook, R. D., Calverley, P. M. A., Celli, B. R., Cowans, N. J., Crim, C. C., Dixon, I. J., Martínez, F. J., et al. (2020) · International Journal of COPD · doi:10.2147/copd.s242809 · Cited by 77
Self-citationComorbidity in chronic obstructive pulmonary disease
Negewo, N. A., McDonald, V. M., & Gibson, P. G. (2015) · Respiratory Investigation · doi:10.1016/j.resinv.2015.02.004 · Cited by 77
“In COPD, however, a paradox exists where mild to moderate obesity is associated with improved survival [47], reduced lung function decline [48–50], and reduced hospital readmission rates [51].”
BackgroundInoue, Y., Kawayama, T., Iwanaga, T., & Aizawa, H. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1701 · Cited by 69
“Previous studies have suggested that risk factors for exacerbation requiring hospitalization include more severe disease, low FEV1, functional dyspnea, advanced age, presence of cardiovascular comorbidities, low body mass index, and low physical activity (21-23).”
BackgroundClinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease
Soeda, S., Ohyashiki, J. H., Ohtsuki, K., Umezu, T., Setoguchi, Y., & Ohyashiki, K. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1251 · Cited by 69
Selection of Candidates for Lung Transplantation
Kreider, M. E., & Kotloff, R. M. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200808-097go · Cited by 77
“More recently, Celli and colleagues incorporated a number of these factors into the multidimensional BODE index (body mass index [B], degree of airflow obstruction [O], dyspnea [D] and exercise capacity [E], measured by the 6-minute walk test) (14).”
BackgroundHoong, J. M., Ferguson, M. L., Hukins, C., & Collins, P. F. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.008 · Cited by 72
Hand grip strength in patients with chronic obstructive pulmonary disease
Jeong, M., Kang, H. K., Song, P., Park, H. K., Jung, H., Lee, S.-S., & Koo, H. (2017) · International Journal of COPD · doi:10.2147/copd.s140915 · Cited by 77
Osadnik, C. R., Loeckx, M., Louvaris, Z., Demeyer, H., Langer, D., Rodrigues, F. M., Janssens, W., Vogiatzis, I., & Troosters, T. (2018) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s174827 · Cited by 68
“The most widely used threshold for this test in patients with COPD is 350 m due to its well-recognized prognostic importance via the BODE index – a multidimensional composite index used to evaluate mortality risk in this patient group.(16,17) The importance of this stratification metric for determining changes in PA a…”
La célula epitelial como factor etiopatogénico de la fibrosis pulmonar
Serrano‐Mollar, A. (2012) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(12)70044-3 · Cited by 73
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction
Bhatt, S. P., Sieren, J. C., Dransfield, M. T., Washko, G. R., Newell, J. D., Stinson, D. S., Zamba, G. K. D., Hoffman, E. A., & for the COPDGene Investigators (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202810 · Cited by 73
Muscle loss contributes to higher morbidity and mortality in COPD : An analysis of national trends
Attaway, A. H., Welch, N., Hatipoglu, U. S., Zein, J., & Dasarathy, S. (2020) · Respirology · doi:10.1111/resp.13877 · Cited by 79
Free-living physical activity in COPD: assessment with accelerometer and activity checklist.
Moy, M. L., Matthess, K. R., Stolzmann, K. L., Reilly, J. J., & Garshick, E. (2009) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2008.07.0083 · Cited by 79
“We calculated the body mass index (BMI), airflow obstruction, dyspnea, exercise capacity (BODE) index, a multidimensional 10-point grading system that assesses COPD severity [29].”
Pleguezuelos, E., Pérez, M. E., Guirao, L., Samitier, B., Costea, M., Ortega, P., González, M. V., Carmen, A. D., Ovejero, L. Q., Moreno, E., et al. (2013) · Respirology · doi:10.1111/resp.12122 · Cited by 75
Rubı, M., Renom, F., Ramis, F., Medinas, M., Centeno, M. J., Górriz, M., Crespí, E., Martín, B., & Soriano, J. B. (2010) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2009.09.025 · Cited by 68
Characteristics of patients admitted for the first time for COPD exacerbation
Balcells, E., Antó, J. M., Gea, J., Gómez, F. P., Rodríguez, E., Marín, A., Ferrer, A., de Batlle, J., Farrero, E., Benet, M., et al. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.04.001 · Cited by 69
Attacking the disease spiral in chronic obstructive pulmonary disease
Polkey, M. I., & Moxham, J. (2006) · Clinical Medicine · doi:10.7861/clinmedicine.6-2-190 · Cited by 69
Prevalence and Determinants of COPD in Spain: EPISCAN II
Soriano, J. B., Alfageme, I., Miravitlles, M., de Lucas, P., Soler‐Cataluña, J. J., Rio, F. G., Casanova, C., González-Moro, J. M. R., Cosío, B. G., Sánchez, G., et al. (2021) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2020.07.017 · Cited by 74
Self-citation
Metadata
- Authors
- Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J.
- Affiliations
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Hospital Clínico Universitario de Caracas (VE)
- Boston University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-03-04
- Volume
- 350
- Issue
- 10
- Pages
- 1005-1012
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139347600
- Semantic Scholar
- 12606ed46f2e1cd6f56b679b445a8fda29690f65
- Cited by
- 4,015
- References
- 36
- Citations by year
- 2026: 88 · 2025: 115 · 2024: 153 · 2023: 132 · 2022: 124 · 2021: 176 · 2020: 199 · 2019: 158 · 2018: 192 · 2017: 184 · 2016: 206 · 2015: 185 · 2014: 241 · 2013: 230 · 2012: 242
- FWCI
- 135.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- chronic obstructive pulmonary disease, BODE index, body mass index, airflow obstruction, dyspnea, exercise capacity, 6-minute walk test, mortality prediction, FEV1, disease severity classification, respiratory mortality
- MeSH terms
- Aged, Airway Obstruction, Dyspnea, Forced Expiratory Volume, Humans, Middle Aged, Prospective Studies, Risk, Risk Factors, Severity of Illness Index, Body Mass Index, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.